Mild hyperthermia with magnetic resonance-guided high-intensity focused ultrasound for applications in drug delivery
Ari Partanen,Pavel S. Yarmolenko,Antti Viitala,Sunil Appanaboyina,Dieter Haemmerich,Ashish Ranjan,Genevieve Jacobs,David L. Woods,Julia Enholm,Bradford J. Wood,Matthew R. Dreher +10 more
TL;DR: An MR-HIFU mild hyperthermia heating algorithm was developed, resulting in accurate and homogeneous heating within the targeted region in vitro and in vivo, which is suitable for applications in drug delivery.
read more
Abstract: Purpose: Mild hyperthermia (40–45 � C) is a proven adjuvant for radiotherapy and chemotherapy. Magnetic resonance guided high intensity focused ultrasound (MR-HIFU) can non-invasively heat solid tumours under image guidance. Low temperature-sensitive liposomes (LTSLs) release their drug cargo in response to heat (440 � C) and may improve drug delivery to solid tumours when combined with mild hyperthermia. The objective of this study was to develop and implement a clinically relevant MR-HIFU mild hyperthermia heating algorithm for combination with LTSLs. Materials and methods: Sonications were performed with a clinical MR-HIFU platform in a phantom and rabbits bearing VX2 tumours (target ¼ 4–16 mm). A binary control algorithm was used for real-time mild hyperthermia feedback control (target ¼ 40–41 � C). Drug delivery with LTSLs was measured with HPLC. Data were compared to simulation results and analysed for spatial targeting accuracy (offset), temperature accuracy (mean), homogeneity of heating (standard deviation (SD), T10 and T90), and thermal dose (CEM43). Results: Sonications in a phantom resulted in better temperature control than in vivo. Sonications in VX2 tumours resulted in mean temperatures between 40.4 � C and 41.3 � C with a SD of 1.0–1.5 � C (T10 ¼ 41.7–43.7 � C, T90 ¼ 39.0–39.6 � C), in agreement with simulations. 3D spatial offset was 0.1–3.2 mm in vitro and 0.6–4.8 mm in vivo. Combination of MR-HIFU hyperthermia and LTSLs demonstrated heterogeneous delivery to a partially heated VX2 tumour, as expected. Conclusions: An MR-HIFU mild hyperthermia heating algorithm was developed, resulting in accurate and homogeneous heating within the targeted region in vitro and in vivo, which is suitable for applications in drug delivery.
read more
Chat with Paper
AI Agents for this Paper
Find similar papers on Google Scholar, PubMed and Arxiv
Write a critical review of this paper
Analyze citations of this paper to find unaddressed research gaps
Citations
Triggered Release from Thermosensitive Liposomes Improves Tumor Targeting of Vinorelbine
Maximilian Regenold,Kan Kaneko,Xuehan Wang,H Benson Peng,James Evans,Pauric Bannigan,Christine Allen +6 more
TL;DR: In this article , the authors explored the therapeutic potential of a thermosensitive liposome formulation of the commonly used chemotherapy drug vinorelbine in combination with mild hyperthermia (39-43 °C) in a murine model of rhabdomyosarcoma.
Targetability of osteoid osteomas and bone metastases by MR-guided high intensity focused ultrasound (MRgHIFU)
TL;DR: MRgHIFU cannot be systematically performed non-invasively on bone tumors and combination with minimally-invasive thermo-protective techniques may increase the number of eligible cases.
Are infectious diseases and microbiology new fields for thermal therapy research
Deniz Gazel,Mehmet Yılmaz +1 more
TL;DR: The potential for local hyperthermia in the treatment of bacterial infections caused by thermo-susceptible pathogens in a systematic plan is highlighted and hypothesized that local heat therapy may become an alternative or adjuvant method for curing local infections.
Novel temperature-triggered liposome with high stability: Formulation, in vitro evaluation, and in vivo study combined with high-intensity focused ultrasound (HIFU)
Sun Min Park,Min Sang Kim,Sang-Jun Park,Eun Sung Park,Kyu-Sil Choi,Young-sun Kim,Hyun Ryoung Kim +6 more
TL;DR: The results indicate that the properties of stability at 37 °C and burst release at 42 °C of STL-DOX act synergistically against tumor growth and inhibition of tumor growth is weak.
A Smart Hyperthermia Nanofiber-Platform-Enabled Sustained Release of Doxorubicin and 17AAG for Synergistic Cancer Therapy.
Lili Chen,Nanami Fujisawa,Nanami Fujisawa,Masato Takanohashi,Masato Takanohashi,Mazaya Najmina,Mazaya Najmina,Koichiro Uto,Mitsuhiro Ebara,Mitsuhiro Ebara,Mitsuhiro Ebara +10 more
TL;DR: In this paper, the authors demonstrate the rational fabrication of a magnetic composite nanofiber mesh that can achieve mutual synergy of hyperthermia, chemotherapy, and thermo-molecularly targeted therapy for highly potent therapeutic effects.
References
Thermal dose determination in cancer therapy
TL;DR: The equations and methods described in this report are intended to provide a simple but effective means for thermal dose estimation for clinical use and to stimulate efforts to evaluate data in terms of therapeutically useful thermal units.
2.4K
Hyperthermia in combined treatment of cancer
Peter Wust,Bert Hildebrandt,G Sreenivasa,Beate Rau,J. Gellermann,Hanno Riess,R. Felix,Peter M. Schlag +7 more
TL;DR: For every particular temperature-dependent interaction exploited for clinical purposes, sophisticated control of temperature, spatially as well as temporally, in deep body regions will further improve the potential.
2K
A precise and fast temperature mapping using water proton chemical shift.
Yasutoshi Ishihara,Calderon A,Hidehiro Watanabe,Kazuya Okamoto,Yoshinori Suzuki,Kagayaki Kuroda +5 more
TL;DR: A new temperature measurement procedure using phase mapping was developed that makes use of the temperature dependence of the water proton chemical shift and highly accurate and fast measurements were obtained during phantom and in vivo experiments.
1K